Newsletter | June 2, 2021

06.02.21 -- Building A Vaccine Company In A Few Months

Building A COVID-19 Vaccine Company In A Few Months

Mei Mei Hu, J.D., and her husband, Lou Reese, know what it’s like to develop a drug during a pandemic. Nearly 20 years ago they helped develop a vaccine and antibody test for the SARS outbreak. But now they were considering starting a COVID-19 vaccine company — during 2020.

An All-Canada COVID-19 Vaccine Solution

The story of how Providence Therapeutics, a Calgary, Ontario-based, emerging mRNA biopharma, came to achieve such notoriety is an interesting one that includes a pivot from its core therapeutic focus, the hiring of an American as company president, and the creation of a CDMO.

Top Five Clinical Development Outsourcing Costs

In a recent survey focused on clinical development outsourcing, respondents reported that their companies outsourced, on average, 61% of their clinical development activities.

From The Editor
Be The Inspiration

The world is hurting. Now, more than ever, people need and want to be inspired by people. Just imagine what we can accomplish if we all strive to be the inspiration we seek.

Taking A Life Sciences Company Public During A Pandemic

In 2020, biotech IPOs shattered all records, and this trend seems to be continuing in 2021. As such, Life Science Leader thought it worthwhile to speak with three life sciences executives about their varied experiences of going public in the middle of a pandemic. 

028: Cell And Gene Bottlenecks And Challenges

Erin Harris, chief editor of, explains what makes cell and gene therapy manufacturing more complex and what some of the current hurdles and bottlenecks are that companies in this sector of life sciences face.

June 2021 Digital Edition

Inside you will find more on:

  • AI In Pharma
  • Drug Development And Partnering
  • Supply Chain Solutions
  • Companies To Watch

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.